Alnylam Pharmaceuticals
ALNY
#640
Rank
NZ$56.26 B
Marketcap
$434.63
Share price
-1.30%
Change (1 day)
76.81%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Cash on Hand

Cash on Hand as of December 2024 : NZ$4.80 Billion

According to Alnylam Pharmaceuticals 's latest financial reports the company has NZ$4.80 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Alnylam Pharmaceuticals - Cash on Hand chart (from 2003 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$3.85 B11.7%
2022-12-31NZ$3.45 B-3.16%
2021-12-31NZ$3.56 B37.26%
2020-12-31NZ$2.59 B13.89%
2019-12-31NZ$2.28 B41.12%
2018-12-31NZ$1.61 B-32.1%
2017-12-31NZ$2.38 B163.07%
2016-12-31NZ$0.90 B-42.68%
2015-12-31NZ$1.57 B77.55%
2014-12-31NZ$0.88 B197.19%
2013-12-31NZ$0.29 B100.41%
2012-12-31NZ$0.14 B-20.41%
2011-12-31NZ$0.18 B-37.92%
2010-12-31NZ$0.30 B-22%
2009-12-31NZ$0.38 B-47.76%
2008-12-31NZ$0.74 B45.68%
2007-12-31NZ$0.50 B65.08%
2006-12-31NZ$0.30 B163.47%
2005-12-31NZ$0.11 B81.38%
2004-12-31NZ$64.53 M80.87%
2003-12-31NZ$35.67 M20.65%
2002-12-31NZ$29.57 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$0.98 B-79.48%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$16.08 B 234.48%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.13 B-55.52%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.72 B-84.92%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.15 B-96.76%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$23.82 B 395.49%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$14.72 B 206.14%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$5.88 B 22.47%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel